← Back to Analyst Consensus 
KOD Buy
Kodiak Sciences Inc.
Current Price —
Implied Upside —
Analysts 11
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 4 reiterations from 3 firms
Next Earnings
Nov 12, 2026 (16 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Sep 28, 2026 | LifeSci Capital | maintain | Outperform → Outperform | — | 57% |
| Sep 28, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Sep 28, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Sep 17, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 17, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 3, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 55% |
| May 11, 2026 | Chardan Capital | upgrade | Neutral → Buy | — | 46% |
| Mar 27, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Mar 27, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Feb 10, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $38 | 44% |
| Jan 22, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $38 | 44% |
| Jan 7, 2026 | UBS | initiate | — → Buy | $50 | 54% |
| Nov 17, 2025 | Chardan Capital | maintain | Neutral → Neutral | $14 | 46% |
| Nov 17, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $26 | 44% |
| Nov 11, 2025 | HC Wainwright & Co. | upgrade | Neutral → Buy | $24 | 44% |
| Oct 24, 2025 | JP Morgan | upgrade | Neutral → Overweight | $24 | 55% |
| Oct 23, 2025 | LifeSci Capital | initiate | — → Outperform | $40 | 57% |
| Oct 6, 2025 | Chardan Capital | maintain | Neutral → Neutral | $14 | 46% |
| Sep 25, 2025 | Barclays | upgrade | Underweight → Equal-Weight | $17 | 53% |
| Sep 22, 2025 | Jefferies | initiate | — → Buy | $15 | 52% |
| Aug 18, 2025 | HC Wainwright & Co. | maintain | Neutral → Neutral | $5 | 44% |
| Aug 14, 2025 | Barclays | maintain | Underweight → Underweight | $7 | 53% |
| Aug 14, 2025 | JP Morgan | upgrade | Underweight → Neutral | $15 | 55% |
| Mar 31, 2025 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $3 | 44% |
| Dec 9, 2024 | Jefferies | upgrade | Hold → Buy | $20 | 52% |
| Nov 15, 2024 | Barclays | maintain | Underweight → Underweight | $4 | 53% |
| Nov 15, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $3 | 44% |
| Sep 24, 2024 | HC Wainwright & Co. | reiterate | Neutral → Neutral | $3 | 44% |
| Sep 5, 2024 | HC Wainwright & Co. | initiate | — → Neutral | $3 | 44% |
| Apr 4, 2024 | UBS | maintain | Neutral → Neutral | $5 | 54% |
| Apr 1, 2024 | Barclays | maintain | Underweight → Underweight | $3 | 53% |
| Dec 21, 2023 | UBS | maintain | Neutral → Neutral | $3 | 54% |
| Nov 17, 2023 | Capital One | upgrade | Equal-Weight → Overweight | $0 | 30% |
| Jul 27, 2023 | UBS | downgrade | Buy → Neutral | $4 | 54% |
| Jul 25, 2023 | Chardan Capital | downgrade | Buy → Neutral | $0 | 46% |
| Jul 25, 2023 | Barclays | maintain | Underweight → Underweight | $2 | 53% |
| Jul 25, 2023 | JP Morgan | downgrade | Neutral → Underweight | $0 | 55% |
| Jul 24, 2023 | Jefferies | downgrade | Buy → Hold | $3 | 52% |
| Jul 24, 2023 | Capital One | downgrade | Overweight → Equal-Weight | $7 | 30% |
| Apr 4, 2023 | JP Morgan | maintain | — → Neutral | $10 | 55% |
| Nov 14, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $9 | 54% |
| Nov 10, 2022 | Goldman Sachs | maintain | — → Neutral | $8 | 54% |
| Aug 15, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $12 | 54% |
| Aug 10, 2022 | Chardan Capital | maintain | — → Buy | $18 | 46% |
| Aug 9, 2022 | Truist Securities | maintain | — → Buy | $15 | 55% |
| Aug 9, 2022 | Goldman Sachs | maintain | — → Neutral | $9 | 54% |
| Aug 2, 2022 | Citigroup | downgrade | Neutral → Sell | $6 | 54% |
| May 24, 2022 | Goldman Sachs | maintain | — → Neutral | $5 | 54% |
| May 17, 2022 | Morgan Stanley | maintain | — → Equal-Weight | $10 | 54% |
Price Target Trend
Jun 28, 2026 Oct 26, 2026
EPS Estimates
0q —
0y —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days